InterCure to Participate in Upcoming Investor Conferences in May 2022

Rhea-AI Summary

InterCure (NASDAQ: INCR), also known as Canndoc, announced participation in two investor conferences in May 2022. The conferences are:

• Canaccord Genuity 6th Annual Cannabis Conference on May 11, 2022
• Cowen 2nd Annual European Cannabis Conference on May 12, 2022

Management will engage in one-on-one meetings at these events. InterCure is recognized as the leading and fastest-growing cannabis company outside North America, with Canndoc being Israel's largest licensed cannabis producer.

News Market Reaction – INCR

-4.15%

-4.15% Session move

In the trading session that priced this news, INCR declined 4.15%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financial Officer, will participate in the following investor conferences in May 2022.

Canaccord Genuity 6th Annual Cannabis Conference
Date: Wednesday, May 11, 2022

Cowen 2nd Annual European Cannabis Conference
Date: Thursday, May 12, 2022

InterCure's management team will be taking part in one-on-one meetings during the conferences. To schedule a one-on-one investor meeting with InterCure's management team, please contact a conference representative or adam@intercure.co.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co

FAQ

What conferences will InterCure (INCR) participate in May 2022?

InterCure will participate in the Canaccord Genuity 6th Annual Cannabis Conference on May 11, 2022, and the Cowen 2nd Annual European Cannabis Conference on May 12, 2022.

Who from InterCure will attend the investor conferences?

Alex Rabinovitch, Chief Executive Officer, and Amos Cohen, Chief Financial Officer, will represent InterCure at the investor conferences.

How can investors schedule a meeting with InterCure's management?

Investors can schedule a one-on-one meeting by contacting a conference representative or emailing adam@intercure.co.

What is the significance of InterCure in the cannabis industry?

InterCure is the leading and fastest-growing cannabis company outside North America, with Canndoc being Israel’s largest licensed cannabis producer.